Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling

Background and Purpose: This pilot randomized controlled trial evaluated the effects of 12 sessions of patient-specific adaptive dynamic cycling (PSADC) versus non-adaptive cycling (NA) on motor function and mobility in individuals with Parkinson’s disease (PD), using inertial measurement unit (IMU)...

Full description

Saved in:
Bibliographic Details
Main Authors: Younguk Kim, Brittany E. Smith, Lara Shigo, Aasef G. Shaikh, Kenneth A. Loparo, Angela L. Ridgel
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/24/22/7364
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846152441874087936
author Younguk Kim
Brittany E. Smith
Lara Shigo
Aasef G. Shaikh
Kenneth A. Loparo
Angela L. Ridgel
author_facet Younguk Kim
Brittany E. Smith
Lara Shigo
Aasef G. Shaikh
Kenneth A. Loparo
Angela L. Ridgel
author_sort Younguk Kim
collection DOAJ
description Background and Purpose: This pilot randomized controlled trial evaluated the effects of 12 sessions of patient-specific adaptive dynamic cycling (PSADC) versus non-adaptive cycling (NA) on motor function and mobility in individuals with Parkinson’s disease (PD), using inertial measurement unit (IMU) sensors for objective assessment. Methods: Twenty-three participants with PD (13 in the PSADC group and 10 in the NA group) completed the study over a 4-week period. Motor function was measured using the Kinesia™ sensors and the MDS-UPDRS Motor III, while mobility was assessed with the TUG test using OPAL IMU sensors. Results: The PSADC group showed significant improvements in MDS-UPDRS Motor III scores (<i>t</i> = 5.165, <i>p</i> < 0.001) and dopamine-sensitive symptoms (<i>t</i> = 4.629, <i>p</i> = 0.001), whereas the NA group did not improve. Both groups showed non-significant improvements in TUG time. IMU sensors provided continuous, quantitative, and unbiased measurements of motor function and mobility, offering a more precise and objective tracking of improvements over time. Conclusions: PSADC demonstrated enhanced treatment effects on PD motor function compared to NA while also reducing variability in individual responses. The integration of IMU sensors was essential for precise monitoring, supporting the potential of a data-driven, individualized exercise approach to optimize treatment outcomes for individuals with PD.
format Article
id doaj-art-a857b584490e4fcd95b0bb379f6052ad
institution Kabale University
issn 1424-8220
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj-art-a857b584490e4fcd95b0bb379f6052ad2024-11-26T18:21:43ZengMDPI AGSensors1424-82202024-11-012422736410.3390/s24227364Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic CyclingYounguk Kim0Brittany E. Smith1Lara Shigo2Aasef G. Shaikh3Kenneth A. Loparo4Angela L. Ridgel5Exercise Science and Exercise Physiology Program, Kent State University, Kent, OH 44242, USAExercise Science and Exercise Physiology Program, Kent State University, Kent, OH 44242, USAExercise Science and Exercise Physiology Program, Kent State University, Kent, OH 44242, USADepartment of Neurology, Case Western Reserve University, Cleveland, OH 44106, USAInstitute for Smart, Secure and Connected Systems, Case Western Reserve University, Cleveland, OH 44106, USAExercise Science and Exercise Physiology Program, Kent State University, Kent, OH 44242, USABackground and Purpose: This pilot randomized controlled trial evaluated the effects of 12 sessions of patient-specific adaptive dynamic cycling (PSADC) versus non-adaptive cycling (NA) on motor function and mobility in individuals with Parkinson’s disease (PD), using inertial measurement unit (IMU) sensors for objective assessment. Methods: Twenty-three participants with PD (13 in the PSADC group and 10 in the NA group) completed the study over a 4-week period. Motor function was measured using the Kinesia™ sensors and the MDS-UPDRS Motor III, while mobility was assessed with the TUG test using OPAL IMU sensors. Results: The PSADC group showed significant improvements in MDS-UPDRS Motor III scores (<i>t</i> = 5.165, <i>p</i> < 0.001) and dopamine-sensitive symptoms (<i>t</i> = 4.629, <i>p</i> = 0.001), whereas the NA group did not improve. Both groups showed non-significant improvements in TUG time. IMU sensors provided continuous, quantitative, and unbiased measurements of motor function and mobility, offering a more precise and objective tracking of improvements over time. Conclusions: PSADC demonstrated enhanced treatment effects on PD motor function compared to NA while also reducing variability in individual responses. The integration of IMU sensors was essential for precise monitoring, supporting the potential of a data-driven, individualized exercise approach to optimize treatment outcomes for individuals with PD.https://www.mdpi.com/1424-8220/24/22/7364wearable technologyneurorehabilitationmotor controlmovement disorders
spellingShingle Younguk Kim
Brittany E. Smith
Lara Shigo
Aasef G. Shaikh
Kenneth A. Loparo
Angela L. Ridgel
Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling
Sensors
wearable technology
neurorehabilitation
motor control
movement disorders
title Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling
title_full Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling
title_fullStr Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling
title_full_unstemmed Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling
title_short Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease After 12 Sessions of Patient-Specific Adaptive Dynamic Cycling
title_sort assessing changes in motor function and mobility in individuals with parkinson s disease after 12 sessions of patient specific adaptive dynamic cycling
topic wearable technology
neurorehabilitation
motor control
movement disorders
url https://www.mdpi.com/1424-8220/24/22/7364
work_keys_str_mv AT youngukkim assessingchangesinmotorfunctionandmobilityinindividualswithparkinsonsdiseaseafter12sessionsofpatientspecificadaptivedynamiccycling
AT brittanyesmith assessingchangesinmotorfunctionandmobilityinindividualswithparkinsonsdiseaseafter12sessionsofpatientspecificadaptivedynamiccycling
AT larashigo assessingchangesinmotorfunctionandmobilityinindividualswithparkinsonsdiseaseafter12sessionsofpatientspecificadaptivedynamiccycling
AT aasefgshaikh assessingchangesinmotorfunctionandmobilityinindividualswithparkinsonsdiseaseafter12sessionsofpatientspecificadaptivedynamiccycling
AT kennethaloparo assessingchangesinmotorfunctionandmobilityinindividualswithparkinsonsdiseaseafter12sessionsofpatientspecificadaptivedynamiccycling
AT angelalridgel assessingchangesinmotorfunctionandmobilityinindividualswithparkinsonsdiseaseafter12sessionsofpatientspecificadaptivedynamiccycling